Ramco Systems: Flying high

Ramco Systems share price hit 5% upper circuit after the company signed an agreement with CHI Aviation to deliver the full suite of Aviation Software, comprising of Maintenance & Engineering, Supply Chain, MRO Sales, Flight Operations, Manufacturing, and Finance.

Following the signing of agreement, Ramco Aviation Suite now maintains the largest numbers of civilian version of CH-47s Helicopters (Chinooks).
This is the third agreement Ramco signed in recent months.
Last week, it won an order from European dairy company, Arla, for modernizing and transforming its multi-country payroll operation.

Arla Foods is World’s largest producer of organic dairy products and global top 10 dairy company. It will implement Ramco Global Payroll & HR software to streamline multi-country payroll and time & attendance operations across 5 Middle East countries on a single platform.
On August 25, the company signed a multi-million dollar agreement with a Malaysian company. The exchange filing of the company further said that the Ramco’s enterprise platform will support in managing more than 50% of all port operations in Malaysia.

The Chennai-based software company in the quarter ended June 30 reported net profit at Rs 14 crore as against Rs 3 crore in the same period last year.
The quarterly order bookings surged 63% over the previous quarter to $21.37 million after it acquired four ‘million-dollar plus’ deals.
Ramco Systems is an enterprise software, offering cloud and mobile-based enterprise software in the area of HCM and Global Payroll, ERP and M&E MRO for Aviation.

Disclaimer –
This document is meant for the recipient only for use as intended and not for circulation. This document should not be reproduced or copied or made available to others. The information contained herein is from the public domain or sources believed to be reliable. While reasonable care has been taken to ensure that information given is at the time believed to be fair and correct and opinions based thereupon are reasonable, due to the very nature of research it cannot be warranted or represented that it is accurate or complete and it should not be relied upon as such. Also above note is not a recommendation to Buy or SELL and is only a view based on facts and figures and we will be in no way responsible for any losses incurred by anyone who uses this information to either trade or invests securities mentioned herein.